DeltaMV Knowledge Solutions Competitors

Oracle is a global leader in AI, delivering the cloud infrastructure, data, and applications that organizations across the world trust to successfully achieve business outcomes at scale. Oracle Cloud Infrastructure (OCI) provides fast, flexible, scalable AI infrastructure. With superior compute performance and network design, a comprehensive choice of AI services for developing and orchestrating agentic AI workflows at scale, and unrivaled data control, security, privacy, and governance, OCI is designed for AI workloads. It also gives customers the flexibility to run their workloads wherever they need by supporting public cloud, multicloud, hybrid cloud, sovereign, and on-premises deployments. The Oracle AI Database is the only database with AI natively built in everywhere. By bringing AI to where data lives, the Oracle AI Database delivers enterprise-grade AI securely, cost-effectively, and at scale. In-database machine learning and vector search enable AI models to run where data resides. Support for multi-modal data (structured, unstructured, graph, vector) enables richer AI use cases. The Oracle AI Data Platform enables organizations to build, deploy, and govern AI agents and applications on top of private, secure, and distributed enterprise data. This enables organizations to operationalize AI without compromising data security or control. Oracle Applications embed AI directly into business workflows and industry processes to ensure AI is delivered in context, where work happens. They include the only applications suite that brings AI to every aspect of a business, with AI-powered ERP, HCM, and CX applications, and the Oracle Health Suite which provides applications for managing the entire healthcare ecosystem. Oracle also provides industry-specific cloud application suites for more than two dozen industries and NetSuite, the world’s first cloud computing company. This LinkedIn page serves as Oracle’s official global company page.

ReSearch Pharmaceutical Services (RPS) merged with PRA in 2013. PRA understands that you want practical solutions that will efficiently and expertly improve your infrastructure to support business needs. Our Strategic Solutions offering provides a broad spectrum of solutions to meet sponsors where they are with their outsourcing needs. As the pioneer of the Embedded SolutionsTM model, we have mastered the art of elegant transformation as sponsors re-align their operating model to more efficiently manage their development portfolio with greater flexibility and control . Our custom-built development solutions empower companies with limited infrastructure to leverage our extensive experience to bring innovative new approaches that enhance quality, streamline development processes and improve efficiency. Our staff augmentation solutions enable sponsors to fill gaps and maintain business continuity seamlessly. For those sponsors desiring an FSP model, we bring years of experience in this method.

Kaiser Permanente's Division of Research (DOR) is one of the nation’s largest research facilities outside of a government or university setting. Our studies cover a wide range of clinical topics, including cardiovascular disease, cancer, diabetes, substance abuse, mental health, maternal and child health, and women’s health. Our research addresses broad issues, including the role of genes and the environment in health, the influence of behavior on disease prevention and chronic illness management, drug safety, health care policy, health services delivery, and disparities. The Division is currently home to 75 research scientists and staff scientists, 17 research fellows, and more than 674 employees. The DOR also has 46 adjunct investigators from within Kaiser Permanente Northern California (KPNC) and other academic institutions. DOR’s scientists are involved in 612 ongoing research projects and the KPNC Clinical Trials Program supports and guides 326 active clinical trials following 3,917 members. Since 2000, DOR researchers have published more than 8,100 peer-reviewed articles, and across all KPNC researchers there were more than 1,000 papers published in 2025 alone.